#News for #media and #investors
At #AIDS2026, Brazilian Ministry of Health announced they will recommend the inclusion of cabotegravir long-acting for PrEP in their public health system (SUS) ahead of review by CONITEC
https://t.co/Lq8qwS8hyg
#News for #Investors and #Media:
At #AIDS2026 we announced new data from the first randomised head-to-head study comparing daily oral 2-drug regimen vs 3-drug regimen in treatment-naïve adults.
Find out more 👉 https://t.co/kkdX3Nw5x5
Today is #ZeroHIVStigmaDay. ❤️
This global movement, launched by NAZ and IAPAC in collaboration with the Global HIV Collaborative and Fast-Track Cities Institute, is dedicated to raising awareness and ending HIV stigma around the world.
Funded by @ViiVHC
#News for #Investors and #Media:
We’ll be at #AIDS2026 presenting research and insights from our innovative portfolio and INSTI-powered pipeline.
Find out more information on our website 👉https://t.co/I9CeGuoCUu
#News for #Media and #Investors: Today we announced paediatric regulatory progress for one of our HIV treatment options, with marketing applications submitted to the EMA and FDA.
👉 Find out more:
https://t.co/P3NVIMgh2a
"It's not just about our survival; it's about the quality of life."— Nicoletta Policek.
Trust and honest clinician‑patient relationships are essential for people growing older with HIV.
Watch Nicoletta explain why shared decision making matters.
#WeWontStop
“Ageing with HIV is brilliant because there is so much that we have experienced as a community that we can bring to the new generation.”
— Nicoletta Policek, EATG.
#WeWontStop#EndingHIV
"HIV is not a solved problem, far from it."
There are more than 30,000 new infections every year and more than 1.2 million people living with HIV in the US.
Full video: https://t.co/1gAiXGMDR1
#WeWontStop#EndingHIV
"Innovation gives me hope.”
Watch Dr. Kimberly Smith talk about how advances in HIV care have made the hard things easier.
Full video: https://t.co/1gAiXGMDR1
#WeWontStop#EndingHIV
#News for #Investors and #Media: Today at #CROI2026 we presented new insights on our investigational ultra-long-acting therapies.
👉 Find out more: https://t.co/P3NVIMgh2a
#News for #Investors and #Media: At #CROI2026 we’re presenting new data focused on informing treatment approaches for children and adolescents living with #HIV.
Learn more 👉 https://t.co/P3NVIMgh2a
Test. Treat. Prevent. Shatter stigma. Ensure access. Keep working towards a cure.
Watch Dr. Kimberly Smith outline the six steps to ending #HIV.
Full video: https://t.co/1gAiXGMDR1
#WeWontStop#EndingHIV
#News for #Investors and #Media: Today at #CROI2026 we announced new analyses from the largest head-to-head randomised clinical trial studying two-regimen vs three-regimen HIV treatments.
#News for #Media and #Investors New data published in the New England Journal of Medicine compare efficacy of different forms of HIV treatment.
https://t.co/G8liY4fW8P
"We have to address stigma. The reality is that it keeps people from getting tested”
Watch Dr. Kimberly Smith discuss why we need more conversations about HIV.
Full video: https://t.co/1gAiXGMDR1
#WeWontStop#EndingHIV
It’s National HIV Testing Week!
HIV can affect anyone – and testing is the only way to know your status.
This week, we’re encouraging everyone to get tested. It’s free, quick and confidential.
Get your free test now: https://t.co/tXRIAbZDTi
Funded by @ViiVHC
Our discussion with @newscientist "Unfinished Business: How do we end HIV?" is officially underway! Join experts Kim Smith, Babafemi Taiwo, @joseph_eron and @SLHWV, as they discuss science, stigma and the future of HIV care. Tune in now!
https://t.co/i9ZAFT7Qc4
Join us and @newscientist for “Unfinished Business: How do we end HIV?”, a fast-paced roundtable discussion with Kimberly Smith, Babafemi Taiwo, @joseph_eron , and @SLHWV tackling the science, stigma and path to a potential HIV-free future.
Register today! https://t.co/i9ZAFT7Qc4